Dividend Stocks Are Booming: Here's How to Grab 4.3% Yields and Monthly Paychecks Right Now
Investors are piling into dividend-paying stocks as a safe way to earn steady income, with top banks and analysts picking defensive healthcare and industrial names that are surging in price and offering yields as high as 4.3%.
Top Wall Street analysts have identified a select group of dividend-paying stocks that can boost portfolio returns, based on strong financial health and consistent payout histories [190051]. UBS, a major global investment bank, says certain defensive stocks—shares in companies that sell essential goods like food, utilities, or healthcare—are "poised to move higher," offering both potential price growth and regular dividend payments [186578]. The healthcare sector surged in June, prompting investment firm Raymond James to add two dividend-paying stocks to its list of top picks, highlighting their strong performance and reliable payouts [187892].
For investors seeking passive income, five companies stand out for their long histories of consistent dividends. Realty Income, a real estate investment trust (REIT) that pays monthly dividends, owns over 13,000 commercial properties leased to tenants like Walmart and Walgreens, and has increased its dividend for 29 consecutive years [189128][186614]. Procter & Gamble has raised its dividend for over 60 consecutive years, selling household essentials that remain in demand even during economic downturns [186614]. Johnson & Johnson, a healthcare conglomerate, has also raised its dividend for 60 consecutive years [186614]. Coca-Cola has paid a dividend for over 100 years and increased it for 60 consecutive years [186614]. AT&T offers a high dividend yield, though it has cut its dividend in the past [186614].
Bristol Myers Squibb offers a dividend yield of 4.3%, higher than the average for large pharmaceutical companies [190078]. The drugmaker generates strong cash from key medicines like Eliquis and Opdivo, but both face patent expirations in the coming years [190078]. The company's dividend payout ratio is about 60% of its earnings, considered manageable, though its debt level is high after recent acquisitions [190078]. For now, the dividend appears secure, but investors should watch for updates on new drug approvals and patent challenges [190078].
JPMorgan Chase has authorized a new $50 billion stock buyback program and increased its quarterly dividend, signaling confidence from the bank's leadership in its financial health and future profits [189137]. Meanwhile, a company aiming to join the exclusive group of Dividend Kings—firms that have raised payouts for at least 50 consecutive years—struggled in the first half of the year due to higher costs and slower demand, but analysts expect improvement in the second half as cost-cutting measures take effect and new products launch [187921].
For those comparing high-dividend exchange-traded funds, the iShares Core High Dividend ETF (HDV) and Fidelity High Dividend ETF (FDVV) both focus on stocks paying above-average dividends [189141]. HDV holds about 75 large U.S. companies with a current yield around 3.5%, favoring defensive sectors [189141]. FDVV holds roughly 120 companies with a slightly higher yield near 3.8%, including more growth-oriented sectors [189141]. The choice depends on an investor's tolerance for sector risk and desire for yield versus stability [189141].